Fluidigm Corporation logo
Fluidigm Corporation FLDM

Fluidigm Corporation Book Value 2011-2025 | FLDM

Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.
What is included in book value
  • Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
  • Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
Features of the metric
  • Assessment of the company's "real" value
    Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account.
  • Comparison with market capitalization
    Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market.
  • Indicator of financial stability
    If the book value is high, it indicates the company has significant assets, which reduces risks for investors.
  • Key component for financial ratios
    Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.

Annual Book Value Fluidigm Corporation

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
132 M - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
132 M 132 M 132 M

Book Value of other stocks in the Diagnostics research industry

Issuer Book Value Price % 24h Market Cap Country
Centogene N.V. Centogene N.V.
CNTG
77.2 M - -6.23 % $ 30.6 M germanyGermany
Akumin Akumin
AKU
141 M - -17.87 % $ 25.9 M canadaCanada
Brainsway Ltd. Brainsway Ltd.
BWAY
75.7 M $ 17.15 1.06 % $ 99.4 M israelIsrael
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
1.85 B $ 15.92 1.08 % $ 171 M chinaChina
Accelerate Diagnostics Accelerate Diagnostics
AXDX
-22.3 M - -61.36 % $ 2.46 M usaUSA
Biocept Biocept
BIOC
8.86 M - -13.05 % $ 7.29 M usaUSA
BioNano Genomics BioNano Genomics
BNGO
35.4 M $ 1.58 -2.78 % $ 2.01 M usaUSA
DarioHealth Corp. DarioHealth Corp.
DRIO
96.4 M $ 12.15 2.14 % $ 345 M israelIsrael
Oxford Immunotec Global PLC Oxford Immunotec Global PLC
OXFD
16.7 M - - $ 562 M britainBritain
DexCom DexCom
DXCM
2.07 B $ 66.09 -1.3 % $ 25.5 B usaUSA
Castle Biosciences Castle Biosciences
CSTL
456 M $ 38.69 0.16 % $ 1.07 B usaUSA
Chembio Diagnostics Chembio Diagnostics
CEMI
17.8 M - 0.22 % $ 16.8 M usaUSA
Exact Sciences Corporation Exact Sciences Corporation
EXAS
2.4 B $ 101.56 0.05 % $ 18.8 B usaUSA
Danaher Corporation Danaher Corporation
DHR
77.5 B $ 227.19 0.3 % $ 166 B usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
1.13 B $ 27.03 -0.41 % $ 817 M usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
4.88 B - - $ 399 M chinaChina
Genetic Technologies Limited Genetic Technologies Limited
GENE
16.4 M - - $ 7.1 B australiaAustralia
Genetron Holdings Limited Genetron Holdings Limited
GTH
548 M - 0.12 % $ 80.1 M chinaChina
DermTech DermTech
DMTK
57.2 M - -11.32 % $ 2.94 M usaUSA
PRA Health Sciences, Inc. PRA Health Sciences, Inc.
PRAH
1.32 B - - $ 10.7 B usaUSA
CareDx, Inc CareDx, Inc
CDNA
261 M $ 19.92 -3.11 % $ 1.07 B usaUSA
Celcuity Celcuity
CELC
116 M $ 102.11 -2.99 % $ 4.03 B usaUSA
Enzo Biochem Enzo Biochem
ENZ
56.1 M - -8.98 % $ 14.8 K usaUSA
Anixa Biosciences Anixa Biosciences
ANIX
18.9 M $ 3.31 -7.68 % $ 106 K usaUSA
Co-Diagnostics Co-Diagnostics
CODX
86 M $ 0.31 -9.31 % $ 9.1 M usaUSA
IQVIA Holdings IQVIA Holdings
IQV
6.07 B $ 223.83 0.72 % $ 40.6 B usaUSA
Guardant Health Guardant Health
GH
-140 M $ 103.97 1.86 % $ 12.8 B usaUSA
Aspira Women's Health Aspira Women's Health
AWH
6.73 M - -6.19 % $ 10.5 M usaUSA
Heska Corporation Heska Corporation
HSKA
422 M - - $ 1.31 B usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
5.39 M - -20.0 % $ 1.06 M usaUSA
Illumina Illumina
ILMN
6.3 B $ 134.95 0.06 % $ 21.5 B usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
3.51 B $ 197.68 2.44 % $ 10.2 B usaUSA
Quotient Limited Quotient Limited
QTNT
-35.6 M - -11.32 % $ 1.1 M schweizSchweiz
Mettler-Toledo International Mettler-Toledo International
MTD
-127 M $ 1 409.44 1.11 % $ 29.9 B schweizSchweiz
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
16.2 B $ 183.97 0.8 % $ 20.4 B usaUSA
Biodesix Biodesix
BDSX
20.9 M $ 7.67 -2.29 % $ 995 M usaUSA
NeoGenomics NeoGenomics
NEO
902 M $ 12.13 2.32 % $ 1.54 B usaUSA
Neogen Corporation Neogen Corporation
NEOG
2.07 B $ 6.82 -0.66 % $ 1.48 B usaUSA
Myriad Genetics Myriad Genetics
MYGN
701 M $ 7.03 -2.57 % $ 637 M usaUSA
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
8.07 B $ 262.25 -0.73 % $ 22 B usaUSA
ICON Public Limited Company ICON Public Limited Company
ICLR
9.52 B $ 185.36 -0.65 % $ 15.3 B irlandaIrlanda
IDEXX Laboratories IDEXX Laboratories
IDXX
1.6 B $ 699.6 -0.65 % $ 57.7 B usaUSA
Lantheus Holdings Lantheus Holdings
LNTH
1.09 B $ 66.88 0.38 % $ 4.63 B usaUSA
Agilent Technologies Agilent Technologies
A
5.39 B $ 140.28 0.44 % $ 42.6 B usaUSA
Biomerica Biomerica
BMRA
4.1 M $ 2.42 -5.19 % $ 5.56 M usaUSA
Bioventus Bioventus
BVS
221 M $ 7.52 -0.46 % $ 471 M usaUSA
Check-Cap Ltd. Check-Cap Ltd.
CHEK
-1.45 M - - $ 9.42 M israelIsrael
Pacific Biosciences of California Pacific Biosciences of California
PACB
701 M $ 2.12 - $ 538 M usaUSA
Motus GI Holdings Motus GI Holdings
MOTS
2.69 M - -34.28 % $ 263 K israelIsrael